18 articles for YJ Shin
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
26
Discovery of 2-(((1r,4r)-4-(((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (Ralinepag): An Orally Active Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension.
Arena Pharmaceuticals
31
Discovery of 11 -hydroxysteroid dehydrogenase type 1 inhibitor.
Incheon National University
32
Discovery of a new series of potent prostacyclin receptor agonists with in vivo activity in rat.
Arena Pharmaceuticals
25
3-Amino-N-adamantyl-3-methylbutanamide derivatives as 11 -hydroxysteroid dehydrogenase 1 inhibitor.
Yonsei University
55
Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.
Sk Biopharmaceuticals
9
Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.
Korea Institute of Science and Technology
31
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile.
Arena Pharmaceuticals
32
Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control.
Arena Pharmaceuticals
4
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.
Arena Pharmaceuticals
27
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
Arena Pharmaceuticals
41
Agonist lead identification for the high affinity niacin receptor GPR109a.
Arena Pharmaceuticals
47
4,5,6-trisubstituted indazole derivatives, and preparation method and pharmaceutical use thereof
Yangtze River Pharmaceutical Group
2
Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.
Hebrew University of Jerusalem
57
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
Cayman Chemical
16
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
Nerviano Medical Sciences